89bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	316.16	55.26	52.46	98.21	93.36	11.26
Short-Term Investments	262.71	132.91	98.29	106.45	0	0
Cash & Cash Equivalents	578.87	188.16	150.75	204.65	93.36	11.26
Cash Growth	207.65%	24.82%	-26.34%	119.21%	729.35%	-
Other Current Assets	14.66	7.92	11.24	5.55	1.97	0.06
Total Current Assets	593.53	196.08	161.98	210.2	95.33	11.32
Property, Plant & Equipment	2.34	0.46	0.15	0.17	0.16	0.03
Other Long-Term Assets	0.4	0.29	0.29	0.71	0.07	0.02
Total Long-Term Assets	2.74	0.74	0.44	0.87	0.23	0.05
Total Assets	596.27	196.82	162.42	211.07	95.55	11.37
Accounts Payable	8.59	12.5	6.84	2.07	0.99	1.51
Current Debt	0.5	0.17	2.5	0	0	0
Other Current Liabilities	20.53	11.94	10.19	6.05	4.62	2.84
Total Current Liabilities	29.61	24.61	19.54	8.11	5.61	4.35
Long-Term Debt	26.61	20.38	16.9	0	0	0
Other Long-Term Liabilities	3.74	0	0.03	0	0	23.07
Total Long-Term Liabilities	30.35	20.38	16.93	0	0	23.07
Total Liabilities	59.96	44.99	36.47	8.11	5.61	27.43
Total Debt	27.11	20.55	19.4	0	0	0
Debt Growth	31.94%	5.92%	-	-	-	-
Retained Earnings	-457.43	-315.24	-213.22	-123.1	-73.6	-16.18
Comprehensive Income	0.19	-0.35	-0.06	-0.01	0	0
Shareholders' Equity	536.31	151.83	125.96	202.96	89.94	-16.06
Net Cash / Debt	551.76	167.61	131.35	204.65	93.36	11.26
Net Cash / Debt Growth	229.19%	27.61%	-35.82%	119.21%	729.35%	-
Net Cash Per Share	7.75	4.82	6.54	12.72	39.83	25.37
Working Capital	563.92	171.47	142.45	202.09	89.72	6.96
Book Value Per Share	7.54	4.36	6.27	12.62	38.37	-36.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).